NCT00720421View on ClinicalTrials.gov

A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Healthy Volunteer
Interventions
DRUG

AZD7325

AZD7325 10 mg oral 2 capsules

DRUG

AZD7325

AZD7325 1 mg oral 2 capsules

DRUG

AZD7325

AZD7325 Placebo oral 2 capsules

DRUG

Lorazepam

Lorazepam 1 mg oral 2 tablets

DRUG

Lorazepam

Lorazepam Placebo oral 2 tablets

Trial Locations (1)

Unknown

Centre for Human Drug Research, Leiden

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY